Endobronchial Ultrasound Biopsy Market Size, Share & Trends Analysis Report By Product (EBUS Scopes, EBUS Needles), By Procedures (EBUS-Transbronchial, Needle Aspiration), By End-use, By Region, And Segment Forecasts, 2025 - 2030

Endobronchial Ultrasound Biopsy Market Growth & Trends

The global endobronchial ultrasound biopsy market size is anticipated to reach USD 966.9 million by 2030 and is anticipated to expand at a CAGR of 4.83% during the forecast period, according to a new report by Grand View Research, Inc. This growth can be attributed to the increasing incidence of cancer, advancements in Endobronchial Ultrasound (EBUS) technology, a rising elderly population, a higher occurrence of respiratory diseases, and the growing acceptance of minimally invasive procedures. For instance, the World Health Organization (WHO) estimates that there will be more than 35 million new cancer cases in 2050, representing a 77% rise from the estimated 20 million cases recorded in 2022.

The endobronchial ultrasound biopsy market is also driven by advancements in medical technology and the increasing prevalence of respiratory diseases. EBUS devices are primarily used for diagnosing lung cancer, tuberculosis, and other respiratory disorders, offering a minimally invasive alternative to traditional surgical biopsies. Technological innovations such as high-resolution imaging, AI-assisted navigation, and improved probe designs have further enhanced the precision and efficiency of EBUS procedures. In addition, the shift toward personalized medicine and early detection strategies in oncology has enhanced demand for these devices, as they support targeted diagnostic interventions that improve patient outcomes.

Moreover, the market's growth is also fueled by demographic trends such as the growing geriatric population, which is more vulnerable to respiratory conditions such as COPD and asthma. For instance, according to the U.S. Census Bureau, around 57.88% of the country’s population was aged 65 years and above in 2023, accounting for 17.5% of the total population. This geriatric population share is further expected to increase over the forecast period. Furthermore, emerging economies are also witnessing market growth due to their large patient pools affected by air pollution-related respiratory disorders. For instance, countries such as China and India have seen increased adoption of EBUS devices due to high rates of lung cancer linked to poor air quality. Moreover, cost-effectiveness compared to invasive alternatives such as mediastinoscopy has made EBUS attractive for healthcare providers.

Endobronchial Ultrasound Biopsy Market Report Highlights

• Based on product, the EBUS scopes segment dominated the market in 2024 with the largest revenue share of 33.0% owing to the demand for minimally invasive diagnostic procedures for lung cancer and mediastinal lymphadenopathy.
• Based on procedure, the EBUS-Transbronchial Needle Aspiration (EBUS-TBNA) segment accounted for the largest revenue share due to its higher diagnostic yield, reduced patient discomfort, and lower complication rates compared to conventional mediastinoscopy, which has increased their adoption among healthcare providers.
• Based on end-use, the hospitals segment dominated the market with the largest revenue share in 2024. This is attributed to the increasing adoption of EBUS biopsy in these healthcare facilities due to its high diagnostic accuracy and reduced patient risk compared to traditional biopsy methods.
• North America held the largest market share of over 29.18% in 2024. This can be attributed to the increasing prevalence of respiratory diseases, such as lung cancer, and the rising demand for minimally invasive diagnostic techniques.

Please note The report will be delivered in 2-3 business days upon order notification. Show more